NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) — According to the study published by P&S Market Research, breast biopsy devices market is forecasted to generate a revenue of $1.4 billion by 2023, the growth is mainly led by product and technological innovations, increasing incidence of breast cancer cases, rising propensity for minimally invasive surgeries, and mounting number of breast cancer screening programs.
On the basis of the procedure conducted for breast biopsy, the market is categorized into vacuum-assisted, core needle, fine needle aspiration, and surgical biopsy. Vacuum-assisted biopsies have been accounting for the largest share in the breast biopsy devices market till now. It is also expected to be the fastest growing category during the forecast period. This can be mainly attributed to its various advantages, such as its ability to precisely locate the area of abnormality using imaging guidance, so that samples are removed only from the region of interest.
Request for Sample Pages: https://www.psmarketresearch.com/market-analysis/breast-biopsy-devices-market/report-sample
On the basis of product, the breast biopsy devices market has been segmented into guidance systems, biopsy needles/guns, biopsy tables, biopsy wires, and other products. Guidance systems are estimated to hold the largest share of 40.1%, in the market in 2017, with its demand majorly driven by the availability of stereotactic breast biopsy and tomosynthesis options in a single system, and the requirement of these systems in all types of surgeries.
During the forecast period, the breast biopsy devices industry is expected to witness the fastest growth in Asia-Pacific (APAC), owing to growing geriatric population, increasing prevalence of breast cancer, growing awareness about breast cancer, rising healthcare expenditure, per capita income, and increasing research in breast biopsy devices in the region. According to National Institute of Cancer Prevention and Research, breast cancer is the most common cancer in women in India and accounts for about a quarter of all cancers in women in Indian cities, and the average age for breast cancer in India is almost a decade lower than that in the West.
According to International Agency for Research on Cancer, in 2012, breast cancer incidences reported in India were 144,937 and the mortality rate in women in India was 70,218, which is comparatively higher than China (47,989). In order to balance these statistics, the government and several other organizations are also creating awareness about breast cancer. For instance, October has been designated as the breast cancer awareness month by the government of India, which is an annual campaign to educate people about breast cancer. Also, the Pink Initiative, a registered charity in Mumbai, creates awareness about breast cancer amongst women in India. These factors cumulatively lead to growth in the demand of breast biopsy devices in the region.
Browse Full Report with detailed TOC on “Breast Biopsy Devices Market” at: https://www.psmarketresearch.com/market-analysis/breast-biopsy-devices-market
Globally, key players in the breast biopsy devices industry are launching products to gain a larger market share. For instance, in November 2017, Siemens Healthineers, a subsidiary of Siemens AG, unveiled its new Mammomat Revelation imaging system at the 2017 Radiological Society of North America (RSNA) Annual Meeting in Chicago. 3D HD Breast Biopsy uses company’s 50-degree wide-angle HD breast tomosynthesis to obtain more targeted, accurate biopsies at a lower dose. The system also offers titanium contrast-enhanced mammography exams and automated breast density measurement.
In August 2017, Hologic Inc. announced the commercial availability of Brevera breast biopsy system with CorLumina imaging technology, in the U.S. The Brevera system provides clinicians with more information at the point of care and results in significant cost and time savings without compromising accuracy or patient health outcomes.
Some of the other major players operating in the breast biopsy devices market include Danaher Corporation, Argon Medical Devices Inc., Becton, Dickinson and Company, Sterylab S.R.L., Scion Medical Technologies LLC, Planmed Oy, Medtronic plc, and Cook Medical LLC.
More Reports Published by P&S Market Research
Surgical Sutures Market
According to the study, the global surgical sutures market is likely to grow from $3.5 billion in 2016 to $4.7 billion by 2023. Treatment of chronic diseases such as cancer, hepatitis, COPD, cardiovascular diseases and other viral diseases such as HIV often require complex surgeries thus, involving suturing. These diseases are persistent and have long-lasting effects on a patient’s health. Therefore, the increasing prevalence of chronic diseases is also a key factor driving the surgical sutures market.
https://www.psmarketresearch.com/market-analysis/surgical-sutures-market
Orthodontic Supplies Market
As per the findings of the research, based on product, the fixed braces held the largest share in the global orthodontic supplies market, primarily due to their efficacy and precision in treating the irregularities in dental structure. Removable braces are expected to register the fastest growth in the orthodontics supplies market during the forecast period. The growth of the removable braces is primarily attributable to increase in the adoption of these braces by adults over traditional braces. Based on end user, children & teenagers are the larger end user in the orthodontic supplies market. Orthodontic treatments are more effective and successful in children and teenagers, as treatment at an early age also prevents the development of serious problems, thereby leading to the larger adoption of orthodontic supplies at this age.
https://www.psmarketresearch.com/market-analysis/orthodontic-supplies-market
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]